-
Perakizumab (INN) is a
humanized monoclonal antibody designed for the
treatment of arthritis. It
binds to IL17A and acts as an immunomodulator. This drug...
- (A, B, C, D, E (interleukin 25), F) Antibodies:
Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:
Iboctadekin Interleukin...
- (A, B, C, D, E (interleukin 25), F) Antibodies:
Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:
Iboctadekin Interleukin...
- Use
Authorization (EUA) COVID-19
Pemtumomab Theragyn mouse MUC1
cancer Perakizumab mab
humanized IL-17A
arthritis Pertuzumab Perjeta mab
humanized HER2/neu...
- (A, B, C, D, E (interleukin 25), F) Antibodies:
Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:
Iboctadekin Interleukin...
- (A, B, C, D, E (interleukin 25), F) Antibodies:
Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:
Iboctadekin Interleukin...
- (A, B, C, D, E (interleukin 25), F) Antibodies:
Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:
Iboctadekin Interleukin...
- (A, B, C, D, E (interleukin 25), F) Antibodies:
Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:
Iboctadekin Interleukin...
- (A, B, C, D, E (interleukin 25), F) Antibodies:
Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:
Iboctadekin Interleukin...
- (A, B, C, D, E (interleukin 25), F) Antibodies:
Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:
Iboctadekin Interleukin...
